Developer docs
API playgroundTry for free, no card

Search company profiles

Mirren

Full company profile

uuid00snxn2

Namestring
Mirren
Legal namestring
Cipla South Africa
Websiteurl
mirren.co.za
Company typeenum
Private
Founded yearint
1983
Descriptiontext

Mirren is a privately held South African pharmaceutical manufacturer founded in 1983 and headquartered in Benoni. According to the firmographic record, the company manufactures a wide range of over-the-counter pharmaceutical products, including tablets, syrups, and specialty creams, serving the South African healthcare market. The company's core technology centers on pharmaceutical manufacturing and drug formulation, operating within a regulated OTC and prescription pharmaceutical value chain.

A significant portion of the input data describes operations of Cipla South Africa, a subsidiary of India's Cipla Ltd., which maintains a diversified portfolio across 23+ therapeutic categories (allergy, antibiotics, asthma, cardiology, HIV, oncology, tuberculosis, etc.) and operates across multiple African markets (South Africa, Kenya, Ghana, Morocco, Egypt). Whether Mirren is operationally connected to, a former name of, or distinct from the Cipla South Africa entity is not clarified in the source data. The data set contains references to SAHPRA regulatory partnerships, a Cipla DNA Academy for healthcare professionals, biosimilars offerings, active pharmaceutical ingredients, and a graduate program — assets that appear to belong to the broader Cipla group rather than to Mirren as an independent OTC manufacturer.

Mirren's business model, as described in the firmographics, is a traditional OTC pharmaceutical manufacturing operation generating revenue through product sales via prescription and healthcare channels, with pricing not publicly disclosed. The company operates as a for-profit private entity with no disclosed headcount, funding history, or customer base. No go-to-motion, GTM channels, or revenue mechanics specific to Mirren are detailed in the source beyond the general statement that the company sells OTC pharma products through prescription and healthcare distribution channels.

Short descriptiontext

Mirren is a privately held South African pharmaceutical manufacturer, founded in 1983 in Benoni, producing over-the-counter products including tablets, syrups, and specialty creams for healthcare consumers.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersBenoni, South Africa
HQ citystring
Benoni
HQ countrystring
South Africa
HQ regionstring
Africa
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
OTC pharmaceutical manufacturing, tablet formulation, pharmaceutical syrups, specialty creams, consumer healthcare products
Industry1 code
PRIMARYHLAIADAN
Vitamins, Minerals & Supplements (VMS)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Manufacturing
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Mirren is a pharmaceutical company that manufactures a wide range of over-the-counter (OTC) pharma products including tablets, syrups, and specialty creams. The company operates as a private, for-profit manufacturer of consumer healthcare dosage forms, serving the South African market from its base in Benoni.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The company operates a diversified pharmaceutical portfolio organized across 23 therapeutic categories covering Allergy, Antibiotics, Asthma, Antifungals, Cardiology, Central Nervous System, Colds & Flu, COVID-19, Dermatology, Deworming, Diabetes, Gastro, Hair Loss, HIV, Immunosuppressants, Men's Health, Oncology, Osteoporosis, Pain, Sexual Health, Tuberculosis, Vitamins & Supplements, Women's Health, and Wound Care. The product portfolio includes specialized offerings such as Biosimilars, a Healthcare Professionals Portal (Cipla DNA Academy), and Active Pharmaceutical Ingredients. This is not a technology/software product offering.

Product and service3 records
1OTC Tablets
CategoryPharmaceutical Product
Description

Over-the-counter pharmaceutical tablets manufactured by Mirren for the South African consumer healthcare market.

2OTC Syrups
CategoryPharmaceutical Product
Description

Over-the-counter pharmaceutical syrups produced by Mirren as liquid dosage forms for consumer healthcare use in South Africa.

3Specialty Creams
CategoryPharmaceutical Product
Description

Specialty topical creams manufactured by Mirren as part of its OTC pharmaceutical offering for the South African market.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Regulatory partnership for product approvals and compliance. SAHPRA Online Directory and OTC Online Directory referenced for medication information compliance in South Africa.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest South African pharmaceutical manufacturer with a similarly broad portfolio across prescription, OTC, and specialty therapeutics. Competes head-to-head in generics and shares the same South African regulatory and pricing environment, making it the most relevant direct comparables.

TypeRegional player
Description

Multinational pharmaceutical company operating through a South African subsidiary in prescription and specialty therapeutics. Competes in oncology, immunology, and cardiovascular categories where Mirren also has offerings.

TypeEmerging player
Description

Indian generics manufacturer expanding in African and emerging markets with focus on TB, cardiovascular, and CNS therapeutics. Partial overlap with Mirren's portfolio and an emerging competitive threat in shared therapy categories.

TypeBroad incumbent
Description

Indian multinational with active expansion into emerging markets including Africa and South Africa. Overlaps in generics, OTC, and select specialty categories where Mirren is present.

5Sun Pharmaceutical Industries
TypeBroad incumbent
Description

World's fourth-largest specialty generics manufacturer with growing presence across Africa. Competes in similar categories (cardiology, CNS, diabetes) and has scale advantages that put pricing pressure on smaller regional players like Mirren.

TypeBroad incumbent
Description

Global generics powerhouse formed by Mylan-Upjohn combination with established South African operations. Competes in ARVs and chronic disease categories that overlap with Mirren's HIV and chronic therapeutic portfolios.

TypeBroad incumbent
Description

Multinational pharmaceutical major with established South African operations spanning prescription, vaccines, and consumer health. Competes across multiple of the same therapy areas, including diabetes, where both companies are present.

TypeBroad incumbent
Description

Indian multinational parent of Mirren and one of the world's largest generic pharmaceutical manufacturers. Direct line-of-sight into Mirren's strategy, pipeline, and pricing, providing both supply and competitive context for the South African subsidiary.

TypeRegional player
Description

Multinational pharmaceutical company with established South African operations across vaccines, specialty, and consumer health. Overlaps with Mirren in respiratory/asthma, dermatology, and OTC consumer health categories.

10Adcock Ingram
TypeDirect peer
Description

Major South African pharmaceutical company spanning prescription, OTC, and consumer health products. Overlaps with Mirren on multiple therapy areas and competes across both retail pharmacy and institutional channels in South Africa.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mirren

Pharmaceutical Manufacturingmirren.co.za

Mirren is a privately held South African pharmaceutical manufacturer, founded in 1983 in Benoni, producing over-the-counter products including tablets, syrups, and specialty creams for healthcare consumers.

What Mirren does

Mirren is a privately held South African pharmaceutical manufacturer founded in 1983 and headquartered in Benoni. According to the firmographic record, the company manufactures a wide range of over-the-counter pharmaceutical products, including tablets, syrups, and specialty creams, serving the South African healthcare market. The company's core technology centers on pharmaceutical manufacturing and drug formulation, operating within a regulated OTC and prescription pharmaceutical value chain.

A significant portion of the input data describes operations of Cipla South Africa, a subsidiary of India's Cipla Ltd., which maintains a diversified portfolio across 23+ therapeutic categories (allergy, antibiotics, asthma, cardiology, HIV, oncology, tuberculosis, etc.) and operates across multiple African markets (South Africa, Kenya, Ghana, Morocco, Egypt). Whether Mirren is operationally connected to, a former name of, or distinct from the Cipla South Africa entity is not clarified in the source data. The data set contains references to SAHPRA regulatory partnerships, a Cipla DNA Academy for healthcare professionals, biosimilars offerings, active pharmaceutical ingredients, and a graduate program — assets that appear to belong to the broader Cipla group rather than to Mirren as an independent OTC manufacturer.

Mirren's business model, as described in the firmographics, is a traditional OTC pharmaceutical manufacturing operation generating revenue through product sales via prescription and healthcare channels, with pricing not publicly disclosed. The company operates as a for-profit private entity with no disclosed headcount, funding history, or customer base. No go-to-motion, GTM channels, or revenue mechanics specific to Mirren are detailed in the source beyond the general statement that the company sells OTC pharma products through prescription and healthcare distribution channels.

Mirren firmographics

Firmographics
Name
Mirren
Legal name
Cipla South Africa
Website
https://mirren.co.za
Company type
Private
Founded year
1983
Operating status
Operating
Short description
Mirren is a privately held South African pharmaceutical manufacturer, founded in 1983 in Benoni, producing over-the-counter products including tablets, syrups, and specialty creams for healthcare consumers.
Ownership category
akta.pro rank

Mirren industry classification

Industry
Product category
Pharmaceutical Manufacturing
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIADAN
Vitamins, Minerals & Supplements (VMS)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

Keywords

  • OTC pharmaceutical manufacturing
  • Tablet formulation
  • Pharmaceutical syrups
  • Specialty creams
  • Consumer healthcare products

Where Mirren is headquartered

Location

Headquarters

HQ city
Benoni
HQ country
South Africa
HQ region
Africa

Offices1 record

Markets served

Mirren business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels1 record

Mirren product offering

Product offering

Core offering

Mirren is a pharmaceutical company that manufactures a wide range of over-the-counter (OTC) pharma products including tablets, syrups, and specialty creams. The company operates as a private, for-profit manufacturer of consumer healthcare dosage forms, serving the South African market from its base in Benoni.

Product overview

The company operates a diversified pharmaceutical portfolio organized across 23 therapeutic categories covering Allergy, Antibiotics, Asthma, Antifungals, Cardiology, Central Nervous System, Colds & Flu, COVID-19, Dermatology, Deworming, Diabetes, Gastro, Hair Loss, HIV, Immunosuppressants, Men's Health, Oncology, Osteoporosis, Pain, Sexual Health, Tuberculosis, Vitamins & Supplements, Women's Health, and Wound Care. The product portfolio includes specialized offerings such as Biosimilars, a Healthcare Professionals Portal (Cipla DNA Academy), and Active Pharmaceutical Ingredients. This is not a technology/software product offering.

Differentiator

Problem solved

Functional benefit

Products and services

  • OTC Tablets Over-the-counter pharmaceutical tablets manufactured by Mirren for the South African consumer healthcare market.
  • OTC Syrups Over-the-counter pharmaceutical syrups produced by Mirren as liquid dosage forms for consumer healthcare use in South Africa.
  • Specialty Creams Specialty topical creams manufactured by Mirren as part of its OTC pharmaceutical offering for the South African market.

Companies that use Mirren

Customer profile

Segments1 record

Ideal customer profiles1 record

Mirren technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Mirren partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

Scale indicators1 record

Recent moves1 record

Expansion highlights3 records

Mirren competitors and assessment

Company assessment

Direct peers

  • Aspen Pharmacare: Largest South African pharmaceutical manufacturer with a similarly broad portfolio across prescription, OTC, and specialty therapeutics. Competes head-to-head in generics and shares the same South African regulatory and pricing environment, making it the most relevant direct comparables.
  • Adcock Ingram: Major South African pharmaceutical company spanning prescription, OTC, and consumer health products. Overlaps with Mirren on multiple therapy areas and competes across both retail pharmacy and institutional channels in South Africa.

Regional players

  • Novartis South Africa: Multinational pharmaceutical company operating through a South African subsidiary in prescription and specialty therapeutics. Competes in oncology, immunology, and cardiovascular categories where Mirren also has offerings.
  • GlaxoSmithKline South Africa: Multinational pharmaceutical company with established South African operations across vaccines, specialty, and consumer health. Overlaps with Mirren in respiratory/asthma, dermatology, and OTC consumer health categories.

Emerging players

  • Lupin Limited: Indian generics manufacturer expanding in African and emerging markets with focus on TB, cardiovascular, and CNS therapeutics. Partial overlap with Mirren's portfolio and an emerging competitive threat in shared therapy categories.

Broad incumbents

  • Dr. Reddy's Laboratories: Indian multinational with active expansion into emerging markets including Africa and South Africa. Overlaps in generics, OTC, and select specialty categories where Mirren is present.
  • Sun Pharmaceutical Industries: World's fourth-largest specialty generics manufacturer with growing presence across Africa. Competes in similar categories (cardiology, CNS, diabetes) and has scale advantages that put pricing pressure on smaller regional players like Mirren.
  • Viatris (Mylan): Global generics powerhouse formed by Mylan-Upjohn combination with established South African operations. Competes in ARVs and chronic disease categories that overlap with Mirren's HIV and chronic therapeutic portfolios.
  • Sanofi South Africa: Multinational pharmaceutical major with established South African operations spanning prescription, vaccines, and consumer health. Competes across multiple of the same therapy areas, including diabetes, where both companies are present.
  • Cipla Ltd. Indian multinational parent of Mirren and one of the world's largest generic pharmaceutical manufacturers. Direct line-of-sight into Mirren's strategy, pipeline, and pricing, providing both supply and competitive context for the South African subsidiary.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Mirren social profiles

Digital presence

Mirren financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mirren leadership team

Management profile

Number of profiles

Mirren funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mirren M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mirren

What does Mirren do?

Mirren is a pharmaceutical company that manufactures a wide range of over-the-counter (OTC) pharma products including tablets, syrups, and specialty creams. The company operates as a private, for-profit manufacturer of consumer healthcare dosage forms, serving the South African market from its base in Benoni.

Is Mirren a public or private company?

Mirren is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Mirren founded?

Mirren was founded in 1983.

Where is Mirren based?

Mirren is headquartered in Benoni, South Africa, in the Africa region.

Who are Mirren's main competitors?

Direct peers on record are Aspen Pharmacare and Adcock Ingram. Regional players are Novartis South Africa and GlaxoSmithKline South Africa. Lupin Limited is listed as an emerging player. Broad incumbents are Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Viatris (Mylan), Sanofi South Africa and Cipla Ltd..

Does Mirren have an API?

No public API is recorded for Mirren.

What industry is Mirren in?

Mirren's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIADAN, Vitamins, Minerals & Supplements (VMS). Its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales